March 28, 2015
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Cancer center names director of clinical research
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Keith Flaherty, MD, has been appointed director of clinical research at Massachusetts General Hospital Cancer Center.
Flaherty succeeds Bruce Chabner, MD, who will assume the title of clinical director, emeritus.
Chabner will continue in his role as an Allen distinguished investigator, and he will continue to be involved with mentoring, grant development, global health and community outreach.
Flaherty will continue to lead the Henri and Belinda Termeer Center for Targeted Therapies, working with pharmaceutical partners to bring new agents to the center and spearhead research into promising new treatment options.